The Manufacturers Life Insurance Company Acquires New Stake in Chemed Corporation $CHE

The Manufacturers Life Insurance Company bought a new stake in Chemed Corporation (NYSE:CHE) during the second quarter, HoldingsChannel.com reports. The institutional investor bought 9,475 shares of the company’s stock, valued at approximately $4,413,000.

Several other institutional investors and hedge funds have also bought and sold shares of CHE. Northwestern Mutual Wealth Management Co. grew its stake in shares of Chemed by 2,444,879.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock valued at $2,374,667,000 after purchasing an additional 5,549,876 shares during the period. BlackRock Inc. bought a new position in shares of Chemed in the 2nd quarter worth approximately $691,290,000. JPMorgan Chase & Co. lifted its stake in shares of Chemed by 4.4% in the 4th quarter. JPMorgan Chase & Co. now owns 521,900 shares of the company’s stock worth $223,301,000 after purchasing an additional 21,932 shares during the period. AQR Capital Management LLC boosted its holdings in shares of Chemed by 89.2% in the fourth quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock worth $139,302,000 after buying an additional 153,469 shares during the last quarter. Finally, TD Asset Management Inc boosted its holdings in shares of Chemed by 7.5% in the fourth quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock worth $138,860,000 after buying an additional 22,715 shares during the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $539.51, for a total value of $1,079,020.00. Following the sale, the chief executive officer owned 70,418 shares in the company, valued at $37,991,215.18. The trade was a 2.76% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Spencer S. Lee sold 1,000 shares of the stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $541.04, for a total transaction of $541,040.00. Following the transaction, the executive vice president directly owned 13,912 shares of the company’s stock, valued at $7,526,948.48. This trade represents a 6.71% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 6,537 shares of company stock valued at $3,406,014. Insiders own 3.33% of the company’s stock.

Chemed Stock Down 1.0%

Shares of CHE opened at $518.26 on Tuesday. The business’s 50 day moving average is $511.08 and its 200 day moving average is $450.15. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $557.00. The company has a market capitalization of $6.77 billion, a PE ratio of 26.03, a price-to-earnings-growth ratio of 1.98 and a beta of 0.51.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, topping the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. During the same period in the prior year, the company posted $4.27 EPS. The firm’s revenue for the quarter was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Research analysts expect that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.

Chemed Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be given a dividend of $0.70 per share. This is a positive change from Chemed’s previous quarterly dividend of $0.60. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Monday, August 17th. Chemed’s dividend payout ratio (DPR) is currently 14.06%.

Analyst Ratings Changes

A number of brokerages have commented on CHE. Oppenheimer upped their target price on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a report on Friday, July 31st. Royal Bank Of Canada lifted their price target on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 30th. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a research report on Saturday, August 1st. Bank of America restated a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Finally, Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $530.75.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.